Par Health Recalls Anesthetic Over Particulate Contamination

The recall affects lots 86930 and 88623, which were distributed to hospital-level wholesalers across the United States between July 2025 and May 2026. While the company reports that no adverse reactions have been documented to date, the presence of foreign matter in an ultra-short-acting barbiturate used for sedation and anesthesia necessitates immediate clinical caution.

Wholesalers and hospital pharmacies holding these specific lots are instructed to stop distribution and use of the vials immediately. Par Health is coordinating the return of the affected inventory through Inmar, Inc. Medical professionals should direct product inquiries to 1-800-828-9393, while facilities with questions regarding the return process should contact Inmar at 1-844-774-1187.